BCR–ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor

Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^{<i>bcr/abl</i>} Gene of the Philadelphia Chromosome

George Q. Daley, Richard A. Van Etten, David Baltimore · Science · 1990 · 2.2K citations · Full text

Life Sciences, Hematology, Oncology +15

Tyrosine Kinase Activity and Transformation Potency of <i>bcr-abl</i> Oncogene Products

T G Lugo, Ann Marie Pendergast, Alexander J. Muller et al. · Science · 1990 · 1.3K citations

Medicine, Molecular Biology, Oncology +14

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

Michael C. Heinrich, Diana Griffith, Brian Druker et al. · Blood · 2000 · 1.1K citations

Life Sciences, Molecular Biology, Pharmacology +16

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity

James B. Konopka, Susan M. Watanabe, Owen N. Witte · Cell · 1984 · 904 citations

Life Sciences, Molecular Biology, Oncology +10

Acute leukaemia in bcr/abl transgenic mice

Nora Heisterkamp, Guido Jenster, Joanne ten Hoeve et al. · Nature · 1990 · 685 citations

Medicine, Genetics, Hematology +10